Neurocrine Biosciences Investments

Neurocrine Biosciences has invested in 1 company and its latest investment was Xenon on Dec 01, 2019

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Xenon is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological disorders.
$30M
Dec 01, 2019
-